Antibody Therapeutics

SJR Rank #4,893H-index: 30SJR: 1.003Best quartile: Q2Open AccessAPC: US$2,822Listed in DOAJ

Journal website: aims, scope and author guidelines

Publisher

Oxford University Press

Country

United States

Type

journal

SJR by Edition

Subject Categories

ImmunologyQ2
Immunology and AllergyQ2

Areas: Immunology and Microbiology · Medicine

Most published research topics

Monoclonal and Polyclonal Antibodies ResearchCAR-T cell therapy researchProtein purification and stabilityHER2/EGFR in Cancer ResearchSARS-CoV-2 and COVID-19 ResearchGlycosylation and Glycoproteins ResearchImmunotherapy and Immune ResponsesViral Infectious Diseases and Gene Expression in Insectsvaccines and immunoinformatics approachesTransgenic Plants and Applications

Source: OpenAlex

Publication Statistics

Documents per Year

Detailed Information

ISSN

2516-4236

SJR Best Quartile

Region

Northern America

Citations per Document (2 years)

4.17

References per Document

84.27

Coverage

2018-2026

Scope

A peer-reviewed, online, open access journal, Antibody Therapeutics provides a forum for the publication of the latest advances and challenges in the discovery, research, development, manufacturing, and methodology of therapeutic antibodies for the global scientific community. Topics include target and antibody discovery, mechanistic research, new technologies and methods, manufacturing, clinical trials, regulation, policies, and more. Antibody Therapeutics article types include original research, reviews, cutting-edge technologies, new methods, news, interviews, and meeting highlights.

Metrics from SCImago Journal Rank 2025. View on SCImago